Shigeto Matsushita

30PUBLICATIONS

93CO-AUTHORS

NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (30)

Sort by Publication Date:

|Jul 07, 2026

Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 14, 2026

Immunotherapy for Cutaneous Squamous Cell Carcinoma in Aging Societies: Integrating Immunosenescence and Geriatric Oncology Perspectives.

Shigeto Matsushita, Kazuyasu Fujii, Megumi Aoki

|Jan 08, 2026

Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 05, 2026

Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Takaya Komori, Eiji Nakano, Yukiko Kiniwa

|Dec 31, 2025

Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Oct 03, 2025

Efficacy and Safety of Helical Tomotherapy Combined With Paclitaxel in Cutaneous Angiosarcoma.

Megumi Aoki, Kazuyasu Fujii, Kentaro Yonekura

Pageof 5

Frequent Collaborators

Taku Fujimura

Takeo Maekawa

Kazuyasu Fujii

Katsuhiko Nishihara

Yasuhiro Fujsawa

Yasuhiro Nakamura

Kentaro Yamamura

Yukiko Kiniwa

Yoshiyuki Nakamura

Takaya Komori

Frequent Collaborators

Taku Fujimura

Takeo Maekawa

Kazuyasu Fujii

Katsuhiko Nishihara